Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn about a recent article by Rahul Gupta et al, published in Nature, adding:
”Has the secret of aging been unlocked?
A groundbreaking Nature study analyzing 750,000 plus
genomes has revealed why our blood cells accumulate mitochondrial DNA mutations as we age—and the answer challenges decades of scientific thinking.
The two-step revelation:
Step 1: Mitochondrial DNA replication errors create low-level ‘cryptic’ mutations in our cells—think of them as hidden genetic typos that go unnoticed.
Step 2: Clonal hematopoiesis (CH) amplifies these mutations by expanding specific cell clones, making the previously invisible mutations detectable.
What makes this paradigm-shifting:
- NOT oxidative stress (the old theory) – Replication errors driving the process
- The mutations are neutral passengers, not drivers of disease—both functional and silent variants accumulate equally in CH carriers
- Clinical impact: Strong associations with myelodysplastic syndrome, leukemias, and chronic kidney disease
- Game-changer: mtDNA mutation burden could detect early CH before traditional screening identifies driver mutations
This elegant work connects three aging hallmarks—mitochondrial mutations, clonal hematopoiesis, and telomere biology—into one unified mechanism.
The implications for early detection and risk stratification in hematologic malignancies are profound.”
Title: Mechanism of age-related accumulation of mtDNA mutations in human blood
Authors: Rahul Gupta, Timothy J. Durham, Grant Chau, Masahiro Kanai, Md Mesbah Uddin, Wenhan Lu, M. Austin Argentieri, Konrad J. Karczewski, Daniel Howrigan, Pradeep Natarajan, Wei Zhou, Benjamin M. Neale, Vamsi K. Mootha

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines